The cost of conducting clinical studies continues to increase for pharmaceutical and biotech companies. For most clinical trials, recruitment accounts for the largest costs, the longest time delays, and the biggest drain on productivity, and is therefore attracting greater management scrutiny. DecisionView commissioned an independent research study to better understand the key clinical recruitment challenges and their magnitude, the requirements for addressing these challenges, and the financial results and benefits of implementing the DecisionView StudyOptimizer solution to improve clinical study performance.
Receive this DecisionView White Paper, please fill out the short form below. Thank you for your interest.
